A smart pill bottle designed to track usage & collect data to aid long term solutions for prescription drug addiction. 




CVS takes action against opioids.




Non-adherence to prescription medication is one of the largest healthcare problems.

Relying on self-reported claims to understand a patients medication adherence lacks. Patients abuse of their prescription leads down a destructive and expensive path. Where things go wrong, however, is hard to track. We took it apon ourselves to create a device that captures the relationship between the patient and their medication in real time. The depth of opioid addiction has been thoroughly researched. But an understanding of how, when, and why people are using at the beginning stages is much more elusive information to obtain. It’s even harder to understand when considering patients who use opioids are rarely honest and forthcoming with their usage. Belay is a backdoor solution to understanding opioid usage trends for long-term analysis.

The healthcare industry has relied on self-reported and claims data to try to understand patient medication adherence. This data lacks timeliness, accuracy, and precision.





With CVS’s recent opioid 7-day policy, Belay would be another initiative in proactively fighting against opioid abuse.

Because they have already taken some serious steps in order to fight the nationwide opioid abuse epidemic, their partnership went without question.

Although there is a risk by taking on such a huge challenge, ethically, however, this move is completely on brand for CVS and fits the customer health-centeredness value. They’ve already stopped selling cigarettes before most of their competitors. As a result, the average smoker smoked 5 fewer pack and 95 million less sold overall. Carving out a health conscious brand is something they take very seriously. Belay is a step in that same direction. It would show CVS as the industry leaders in responsibility when it comes to prescription drugs.

“I think as health care stakeholders we all play an important role in being part of the solution.”
— CVS Health CEO Larry Merlo


Step by step instructions



Belay is a smart bottle

Built to discover long-term insights into opioid usage as well as assist patients in the early stages of the opioid cycle. It is build with security, weight, and tracking features that allow the bottle to properly monitor opioid usage from patient to patient. Patients will be given the opportunity to use their Belay bottle in cognizance with an app that will guide them through their opioid usage.

However, this bottle has no features set on stopping one from taking their medication. It is built to help understand opioids for patients.

In its efforts to help consumers, it works to data mine by compiling thousands of user profiles into statistical points. These plot points are sent for educational use to the National Institute on Drug Abuse. There, the National Institute on Drug Abuse can observe user habits, usage cycles and trends into opioid usage and determine specific hypothesis and solutions to counter the epidemic.

Belay is a seamless piece of medical tech that doesn’t affect any part of the current pharmaceutical landscape. It is made to be easy for all parties involved with an emphasis on data mining to research and prevent opioid usage in the future.






It's simple and effective

The Belay app will be available for patients to track their usage. They will be able to monitor personal trends, when they use most, their next prescription, and other valuable information. See below for details into the app.




Opioid addiction has been thoroughly documented throughout the years.

But almost all research dedicated to opioids requires patients to fill out a survey about their usage. When considering patients are rarely honest with their usage and/or have a hard time recalling it, surveys and doctor visits aren’t an effective way to gain an edge on the opioid epidemic.

Belay cuts past these issues by conducting unblemished data through the use of the Belay bottle. The data acquired will delve into opioid usage with a deeper understanding of its habituation use. For instance, Belay will illuminate what time people use most, if early user binge use at specific times, when addiction trends take place, and many more deeper insights not yet documented. These data points can be instrumental in creating newer hypotheses into opioid usage. With the Belay smart bottle, opioid research will be more accurate, thorough, and pointed than ever. Research administrations like the National Institute on Drug Abuse will be able to see the compiled data in statistical diagrams and dissect new found issues into the crisis. They will be able to form new solutions to the most current issues and keep countless patients from turning their prescription into an addiction.





Style Guide

The design of the bottle is made to differentiate it from the typical pharmaceutical bottles. The pills in this bottle are much more serious than the average antibiotic or blood thinner and it’s important for people to consider that overtime they unlock their bottle. In that same essence, the colors we chose for the app are more bold and cautionary. We use a burnt orange that is closer to red and typefaces that give a sense of urgency and responsibility to the app. As for the logo, Belay helps people from falling into addiction from a macro and micro sense. That’s the reason we chose the name Belay, and the reason we used the idea of a carabiner in our logo design.